|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
See Header: Adverse effect of unsp drug/meds/biol subst
ICD-10 (CM) Code and Descriptor
|
T50.905D |
Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter
|
T50905D utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 12.75%
|
18.40%
|
18.46%
|
14.21%
|
9.28%
|
6.87%
|
4.50%
|
3.35%
|
2.75%
|
2.68%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T50.905D*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
519
|
519
|
|
80053
|
COMPREHEN METABOLIC PANEL |
427
|
427
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
398
|
398
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
358
|
358
|
|
80061
|
LIPID PANEL |
286
|
286
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
175
|
175
|
|
95076
|
INGEST CHALLENGE INI 120 MIN |
96
|
96
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
91
|
91
|
|
95018
|
ALL TSTG PERQ&IQ DRUGS/BIOL |
84
|
725
|
|
84443
|
ASSAY THYROID STIM HORMONE |
83
|
83
|
|
G0467
|
FQHC VISIT, ESTAB PT |
70
|
70
|
|
82306
|
VITAMIN D 25 HYDROXY |
64
|
64
|
|
80048
|
METABOLIC PANEL TOTAL CA |
62
|
62
|
|
80076
|
HEPATIC FUNCTION PANEL |
56
|
56
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
56
|
56
|
|
83735
|
ASSAY OF MAGNESIUM |
55
|
55
|
|
82607
|
VITAMIN B-12 |
48
|
48
|
|
84439
|
ASSAY OF FREE THYROXINE |
45
|
45
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
43
|
43
|
|
85027
|
COMPLETE CBC AUTOMATED |
42
|
42
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T50.905D related to the following DRG Codes:
949-950
|
